Cite
HARVARD Citation
Hoyer, D. et al. (2022). HTK‐N as a new preservation solution for human kidney preservation: Results of a pilot randomized controlled clinical phase II trial in living donor transplantation. Clinical transplantation. 36 (3), p. n/a. [Online].